Yahoo
TSXV - Delayed Quote CAD

Hydreight Technologies Inc. (NURS.V)

3.1300 -0.4200 (-11.83%)
At close: October 30 at 3:59:58 PM EDT
Chart Range Bar
Loading chart for NURS.V
  • Previous Close 3.5500
  • Open 3.5100
  • Bid 3.1300 x --
  • Ask 3.4100 x --
  • Day's Range 3.0000 - 3.5400
  • 52 Week Range 2.3800 - 5.5900
  • Volume 147,832
  • Avg. Volume 84,550
  • Market Cap (intraday) 167.992M
  • Beta (5Y Monthly) 0.63
  • PE Ratio (TTM) 24.08
  • EPS (TTM) 0.1300
  • Earnings Date (est.) Nov 26, 2026
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est 7.92

Hydreight Technologies Inc. operates in the digital health technology sector in the United States. The company develops a proprietary telemedicine service that allows users to book confidential health and wellness, and/or medical services through a mobile application. It also provides consulting and advice in setting up health and wellness services, including assistance with finding experienced advisors in the areas of medical and privacy law, among others; medical liability insurance; pharmaceutical IV programs vetted by duly licensed pharmacists; procedural guides with respect to various services, such as a range of IV therapy treatments, GLP1, NAD, Botox, and fillers; and hiring, on-boarding, training, marketing, branding, payroll, and other accounting services. In addition, the company offers an online pharmacy, which allows its network of medical practitioners to purchase pharmacy products from federally regulated pharmacies. Hydreight Technologies Inc. is headquartered in Las Vegas, Nevada.

hydreight.com

--

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

NURS.V
27.21%
S&P/TSX Composite index (^GSPTSE)
11.78%

1-Year Return

NURS.V
33.40%
S&P/TSX Composite index (^GSPTSE)
18.03%

3-Year Return

NURS.V
943.33%
S&P/TSX Composite index (^GSPTSE)
88.90%

5-Year Return

NURS.V
3,030.00%
S&P/TSX Composite index (^GSPTSE)
69.32%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 28.03M
Earnings 2.53M
Profit Margin 9.02%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
5M
10M
15M
20M
25M
4.0%
6.0%
8.0%
10.0%

Analyst Insights

View More

Analyst Price Targets

6.75
7.92 Average
3.1300 Current
9.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    8.59%

  • Return on Assets (ttm)

    11.71%

  • Return on Equity (ttm)

    31.44%

  • Revenue (ttm)

    78.43M

  • Net Income Avi to Common (ttm)

    6.74M

  • Diluted EPS (ttm)

    0.1300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    19.97M

  • Total Debt/Equity (mrq)

    22.28%

  • Levered Free Cash Flow (ttm)

    -16.48M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: